Multi-Center Study of the Effect of Sevelamer Carbonate (Renvela) on Metabolic/Inflammatory/ROS in Diabetics With Nephropathy
Phase of Trial: Phase II
Latest Information Update: 07 May 2015
At a glance
- Drugs Sevelamer (Primary) ; Calcium carbonate
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 08 Apr 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 31 May 2012 Actual initiation date (February 2012) added as reported by ClinicalTrials.gov.
- 31 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.